GovWire

Guidance: Innovation pathway for NHS products

Accelerated Access Review

May 25
15:02 2016

Details

This draft document provides guidance for the entire innovation pathway from product idea to adoption and uptake by the NHS for the following product types:

  • pharmaceuticals
  • medical devices and diagnostics
  • digital health

For each stage of the pathway, it also includes a checklist of what to consider and details of the main organisations and contacts.

This draft guide has been designed for innovators and the life sciences and health tech industry and is particularly aimed at small and medium-sized enterprises (SMEs).

The Accelerated Access Review (AAR), which aims to speed up access to innovative drugs, devices and diagnostics for NHS patients, found that SMEs can find it difficult to navigate the innovation pathway. The Reviews interim report proposed the idea of how to guides that help SMEs and make the process clearer for all.

It has been developed in consultation with stakeholders, including SMEs. This edition is a first draft and the review team are gathering feedback on what improvements can be made to inform a revised version to be published later this year. Please send any comments to acceleratedaccess@officeforlifesciences.gsi.gov.uk

The guide will be updated to reflect any changes once the AARs final report has been published and implementation agreed.

Published 25 May 2016

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: